Finanzwire Finanzwire
Basculer en Français
11331 Companies
251854 Keywords
181108 Articles
137644 Press releases
Headlines Articles Press releases Meril Life Sciences Remove
  1. Home
  2. Companies
  3. Meril Life Sciences
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/21/2025 at 11:15, 11 months 21 days ago

    Meril Life Sciences Unveils One-Year Results from LANDMARK Trial

    Clinical Outcomes Meril Life Sciences LANDMARK Trial Myval THV Aortic Stenosis
  • PRESS RELEASE

    published on 11/21/2025 at 11:10, 11 months 21 days ago

    Meril Life Sciences Presents One-year Outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025

    Meril Life Sciences presents one-year outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025, comparing THV series in aortic stenosis patients. Study highlights Myval THV series performance in clinical efficacy and patient safety
    Meril Life Sciences LANDMARK Trial Aortic Stenosis PCR London Valves 2025 THV Series
    Logo of Meril Life Sciences
Accesswire
  • Published on 11/12/2026 at 23:05, 9 minutes ago

    Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend

  • Published on 11/12/2026 at 23:00, 14 minutes ago

    Redwood AI Announces Chemical Risk Analysis Update to its AI-Powered Reactosphere Platform to Support Faster Reaction Safety Screening

  • Published on 11/12/2026 at 22:50, 24 minutes ago

    First Canadian Graphite Closes Over-Subscribed Financing

  • Published on 11/12/2026 at 22:30, 44 minutes ago

    Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update

  • Published on 11/12/2026 at 19:20, 3 hours 54 minutes ago

    HELLENiQ ENERGY Holdings S.A Announces 3Q 2026 Financial Results

View all ACCESSWIRE
EQS Group
  • Published on 11/12/2026 at 22:35, 38 minutes ago

    Silverfort Named a Leader in the IDC MarketScape for Worldwide Augmented Identity Security Solutions 2026 Vendor Assessment

  • Published on 11/12/2026 at 19:50, 3 hours 23 minutes ago

    Eurobattery Minerals receives shareholder requests for additional items on the agenda of the upcoming Extraordinary General Meeting

  • Published on 11/12/2026 at 18:25, 4 hours 48 minutes ago

    OMAN AWARDS TWO GREEN HYDROGEN PROJECTS IN DUQM AND LAUNCHES ROUND 4 GREEN-POWERED DATA CENTRE HYDROGEN AUCTION AT COP31

  • Published on 11/12/2026 at 18:14, 4 hours 59 minutes ago

    EQS-Adhoc: HUGO BOSS AG: Daniel Grieder to step down as CEO of HUGO BOSS effective December 31, 2026 - David Epstein appointed as CEO effective January 1, 2027

  • Published on 11/12/2026 at 18:00, 5 hours 13 minutes ago

    Deutsche EuroShop on track – 2026 forecast raised

View all EQS
Les Echos
  • Published on 11/12/2026 at 18:36, 4 hours 37 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026

  • Published on 11/12/2026 at 18:00, 5 hours 14 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026

  • Published on 11/12/2026 at 17:40, 5 hours 34 minutes ago

    Financial information for the period ended 30 September 2026

  • Published on 11/12/2026 at 08:56, 14 hours 17 minutes ago

    Number of shares and voting rights - October 2026 (In French only)

  • Published on 11/12/2026 at 08:40, 14 hours 34 minutes ago

    FREY forms a €400 million equity partnership with GIC to invest in premium European retail parks

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy